Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities Vincent BauchauKourtney DavisJamie Wilkins Current Opinion Open access 11 April 2023 Pages: 327 - 333
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22 Harrison S. FranceJeffrey K. AronsonGeorgia C. Richards Original Research Article 22 February 2023 Pages: 335 - 342
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System Salvatore CrisafulliPaola Maria CutroneoGianluca Trifirò Original Research Article Open access 15 February 2023 Pages: 343 - 355
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study Comfort K. OgarJonathan QuickJean Claude Mugunga Original Research Article Open access 22 February 2023 Pages: 357 - 370
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data Hiroki YamamotoGen KayanumaShuji Kaneko Original Research Article Open access 24 February 2023 Pages: 371 - 389
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose Monika RaethkeFlorence van HunselMiriam Sturkenboom Original Research Article 07 April 2023 Pages: 391 - 404
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends Nelly F. LyClare FlachDeborah Layton Original Research Article 28 March 2023 Pages: 405 - 416
The Rationale for Robust Pharmacovigilance in Monitoring the Safety of Traditional Medicines and Natural Health Products Rhiannon Braund Book Review 29 March 2023 Pages: 417 - 418
Conference on Advances in Pharmacovigilance for Herbal Medicines 12th–14th April 2023 Abstract 30 March 2023 Pages: 419 - 431
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review Benjamin KompaJoe B. HakimAndrew L. Beam Correction Open access 24 February 2023 Pages: 433 - 433